CLEC14A was up-regulated in hepatocellular carcinoma and may function as a potential diagnostic biomarker. Clinics, [S. l.], v. 77, p. 100029, 2022. DOI: 10.1016/j.clinsp.2022.100029. Disponível em: https://journals.usp.br/clinics/article/view/213315.. Acesso em: 18 jun. 2024.